CHGCY News and Press, Chugai Pharmaceuticals Co. Ltd. ADR From 04/20/20

Shares of Verastem Oncology   (NASDAQ: VSTM) , a biotechnology company developing new cancer drugs, are on the rise again after the company announced an upcoming conference call. Investors excited to hear what management will have to say about an investigator-initiated study (i.e., on...

Drivers of the multi-year underperformance US Healthcare is the 2nd largest equity sector, with a 14% index weight , and has been a perennial underperformer the last five years (see chart), and lagged by 10 points last year alone. This was even as the sector has continued to post robust g...

Introduction - good things may be happening here I stopped trading or commenting on Alexion ( ALXN ) in the first half of 2017, when there were countless uncertainties. ALXN was around $110 and was sold at a small loss. ALXN closed Wednesday at $125.18, lagging the market ( SPY ) and a major...

The FDA designates Chugai Pharmaceutical's ( OTCPK:CHGCY ) Phase 3-stage satralizumab, an IL-6 receptor humanized recycling antibody, a Breakthrough Therapy for the treatment of neuromyelitis optica and neuromyelitis optica spectrum disorders (NMO/NMOSD), autoimmune dysfunctions primaril...

The following slide deck was published by Chugai Pharmaceutical Co., Ltd. ADR in conjunction with their 2018 Q2 earnings Read more ...

This article is the second of two parts discussing Alexion Pharmaceuticals ( ALXN ) and its competition. Make sure to check out Part 1 here if you have not already. In Part 2 I will focus mostly on ALXN’s competition. I have previously reviewed a large number of ALXN’s compet...

The following slide deck was published by Chugai Pharmaceutical Co., Ltd. ADR in conjunction with their 2018 Q1 earnings Read more ...

Industry Developments James Watson, who co-discovered the double-helix structure of DNA in 1953, will lead a new international life science research center in the International Bio Valley, located in Shenzhen's Dapeng New Area. A groundbreaking ceremony was held last Friday with Dr. Watson i...

The following slide deck was published by Chugai Pharmaceutical Co., Ltd. ADR in conjunction with their 2017 Q4 earnings Read more ...